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Abstract
A novel oxime grafting scheme was utilized to conjugate an ICAM-1 ligand (LABL), a cellular
antigen ovalbumin (OVA), or both peptides simultaneously to hyaluronic acid (HA). Samples of
HA only and the various peptide grafted HA were found to bind to dendritic cells (DCs). HA with
grafted LABL and OVA showed the greatest binding to DCs. Dendritic cells treated with HA, HA
with grafted LABL, or HA with grafted LABL and OVA, significantly suppressed T cell and DC
conjugate formation, T cell proliferation and reduced proinflammatory cytokine production
compared to untreated cells. These results suggest that HA serves as an effective backbone for
multivalent ligand presentation for inhibiting T cell response to antigen presentation. In addition,
multivalent display of both antigen and an ICAM-1inhibitor (LABL) may enhance binding to DCs
and could potentially disrupt cellular signaling leading to autoimmunity.
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INTRODUCTION
An ideal therapeutic intervention for autoimmune diseases would eliminate the cells that are
actively involved in the pathogenesis of the autoimmune disease while maintaining
protective immune responses. Strategies have been explored to selectively block major
histocompatibility complex class II (MHCII) molecules associated with each autoantigen. In
this approach, targeting only the subpopulation of offending antigen presenting cells (APCs)
or antigen primed T cells could minimize global immunosuppression. For example, antigen-
specific inhibition of the immunological synapse (IS) by simultaneously blocking antigen
recognition and costimulation has been explored.1, 2
Receptors participating in adhesion or costimulation have become attractive targets for
immune suppression. Additionally, a number of antigen peptide analogs have been shown to
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antigen specific T cells and also a reduction in T cell proliferation.3 Cell-cell communication
at the IS includes both of these signals and others, orchestrated in thousands of receptor-
ligand interactions. Receptor valency, geometry, and binding duration within the IS are well
known factors affecting T cell activation.4–8
In these studies, ovalbumin antigen (ISQAVHAAHAEINEAGR) and a peptide capable of
targeting and blocking ICAM-1 (ITDGEATDSG) were conjugated to hyaluronic acid (HA)
using a variation of traditional aminooxy chemistry.9–11 The resulting graft polymer
constructs displayed multiple copies of antigen, ICAM-1 blocking peptide (LABL), or a
combination of both antigen and LABL. These graft polymers were then dosed in cell
culture. The HA graft polymers were studied as potential inhibitors of the IS using a primary
cell co-culture system consisting of DCs and T cells that present and recognize OVA,
respectively. HA graft polymers with OVA antigen, LABL, or a 1:1 ratio of these peptides
were explored to determine DC binding and subsequent DC-T cell conjugation, T cell
proliferation, and cytokine production.12
RESULTS
Characterization of HA graft polymers
The conjugation of peptides to HA was achieved via a modified oxime chemistry scheme as
previously reported.11 An aminooxy group was added to the N-terminus of the synthesized
peptides to facilitate reaction to the HA backbone. After reaction, unreacted free peptide was
removed through extensive dialysis. Reacted LABL and OVA peptides were quantified after
the conjugation reaction via HPLC. Both LABL and OVA peptides were grafted to HA with
similar ratios for graft polymers with only one peptide. The graft polymer with both peptides
had an approximate 1:1 ratio of LABL and OVA, but approximately the same total peptide
content as the other graft polymers as illustrated by total peptide number. The types of
samples prepared and the peptide content of each polymer can be found in Table 1.
Additionally, the stability of the HA backbone as well as the HA graft polymers in RPMI
media was assessed. These experiments were performed at conditions equal to that of the
cell culture to ensure that the HA or the graft polymers were not degrading during the time
of the experiment. The gel permeation chromatography data showed that even after 48 hours
incubation in RPMI media at 37 °C both the HA and the graft polymer chromatograms
remained unchanged, suggesting stability at these conditions during the experimental time
frame. A representative chromatogram for the HA-LABL graft conjugate is shown in
Supplemental Figure 1.
Binding of HA graft polymers to DCs
The binding of HA, HA with grafted LABL, HA with grafted OVA, or HA with grafted
LABL and OVA to DCs was investigated in vitro by fluorescence microscopy and
fluorescence spectroscopy. DCs were matured with TNF-α and loaded with OVA for 24
hours prior to addition of HA graft polymers labeled with the fluorophore FITC.
Fluorescence microscopy revealed that DCs incubated for 15 min with HA with grafted
LABL or HA with grafted LABL and OVA exhibited ~2 and 2.5 fold higher fluorescent
intensities than DCs incubated with HA, respectively. DCs incubated with HA with grafted
LABL and OVA were significantly more fluorescent than those treated with HA with
grafted LABL (Figure 1A and B). The result was confirmed by fluorescence spectroscopy.
Incubating DCs with HA with grafted LABL or HA with grafted LABL and OVA resulted
in a significant increase in fluorescence intensity of DCs when compared to HA (Figure 1C).
HA alone also showed substantial binding to DCs, as expected, since HA is a ligand for
many different cell surface molecules such as CD44 present on cells, such as fibroblasts,
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smooth muscle cells, epithelial cells and immune cells such as DCs, neutrophils,
macrophages, and lymphocytes.13, 14
It has been previously reported that free synthetic peptides can also bind directly to unloaded
MHCII molecules and be recognized by T cells specific for that antigen.15–18 The higher
fluorescence induced by HA with grafted LABL and OVA suggested that a binding event
involving the OVA peptide may have augmented the fluorescence. The HA with grafted
OVA alone did not bind DC efficiently. Furthermore, the reduction in fluorescence
suggested the grafting of OVA may have hindered the binding of HA to nonspecific cell
surface molecules. It was unclear whether OVA may provide a small enhancement in the
binding of grafted HA polymers when co-grafted with LABL, even though some have
suggested that “unloaded” MHC may bind free antigen with low affinity. 16–18
T cell proliferation was reduced by the HA graft polymers
The degree of T cell proliferation was determined after co-culture with DCs loaded with
OVA and matured with TNF-α. After priming and maturation, DCs were pretreated with
HA, HA with grafted LABL or HA with grafted LABL and OVA for 30 min. Then, these
treated DCs were co-cultured with OVA specific T cells. After 24 hours (day 1) and 168
hours (day 7), OVA-specific T cell proliferation was measured by dilution of fluorescent
dye (CFSE) using a FACScan flow cytometer. The percent of T cell proliferation was
analyzed by calculating the percent of cells with diluted CFSE using FlowJo software. Both
the HA with grafted LABL and OVA and the HA with grafted LABL incubated with DCs
led to a statistically significant decrease in the number of T cells that had divided compared
to the untreated group (Figure 2). There was no significant difference in the level of T cell
proliferation between DCs treated with HA compared to untreated DCs. T cells alone
without DCs were used as a negative control and yielded a T cell proliferation of only
~0.6%.
HA and HA graft polymers reduced cytokine production of DCs and OT-II T cells
Blocking of T cell proliferation by HA and HA graft polymers suggested that HA and HA
graft polymers may also change cytokine production. To determine the effect of HA and HA
graft polymers on cytokine production, DCs were again matured with TNF-α and loaded
with OVA in a manner similar to the T cell proliferation study. These DCs were treated with
HA, HA with grafted LABL or HA with grafted LABL and OVA for 30 minutes, washed
with PBS, and co-cultured with primary OT II T cells for 7 days. TNF-α, IFN-γ, IL-4, IL-10
and IL-17 were then quantified by ELISA. After 7 days, all co-cultures of DCs and T cells
had undetectable levels of IFN-γ, IL-4, and IL-10.
When compared to untreated DCs, the levels of TNF-α and IL-17 were significantly reduced
in the presence of HA, HA with grafted LABL and HA with grafted LABL and OVA
(Figure 3). The amount of TNF-α in the medium of cells exposed to HA, HA with grafted
LABL or HA with grafted LABL and OVA was reduced from 10.9 (untreated) to 3.7, 4.1
and 8.2 ng/mL, respectively (Figure 3A). When T cells were cultured by themselves, there
was little to no increase seen in TNF-α level. This result suggested that the production of
TNF-α by DCs, which can induce inflammation, was inhibited in the presence of HA and
HA graft polymers.19 Since TNF-α promotes inflammatory responses, TNF-α can lead to
the pathogenesis of various inflammatory and autoimmune diseases.20 Blockade of TNF-α
has shown therapeutic efficacy in a number of T cell-dependent autoimmune diseases such
as rheumatoid arthritis, juvenile idiopathic arthritis, Crohn’s disease, inflammatory bowel
disease and psoriasis.20, 21
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IL-17 has been associated with the pathogenesis of a wide range of inflammatory and
autoimmune diseases including asthma, psoriasis, rheumatoid arthritis, inflammatory bowel
disease, systemic sclerosis and systemic lupus erythematosus.22, 23 IL-17 produced from
untreated cells was 13.9 ± 0.7 ng/mL, whereas the amount of this cytokine secreted from
cells in the presence of HA and HA graft polymers was below the limit of detection, < 2pg/
mL (Figure 3B). The decrease in cytokine production suggested that HA and HA graft
polymers may have inhibited the differentiation of Th17 CD4 cells. The binding of HA and
HA graft polymers to DC inhibited T cell and DC immunological synapse formation, which
may inhibit T cell proliferation and any ensuing cytokine production (Figure 3). While some
portion of T cells died after 7 days of incubation, the T cell proliferation assay measures
dilution of the fluorescent dye thus normalizing all data across the study. Therefore, despite
some expected T cell death, co-culture of T cells and DCs is sufficient to induce T cell
proliferation and to activate TNF-α expression, as well as achieve statistically significant
cytokine levels.
HA with grafted LABL, and HA with grafted LABL and OVA, showed increased binding to
DCs, a reduction in T cell and DC conjugate formation, T cell proliferation, and suppression
of TNF-α and IL-17 production. Additionally, these HA graft polymers did not show
increased levels of IFN-γ, IL-4 and IL-10. These data suggest HA graft polymers displaying
a cell adhesion antagonist, or a cell adhesion antagonist and antigen may be useful for
targeting dendritic cells involved in inflammatory and autoimmune diseases as multivalent,
antigen-specific immune modulators.
HA and HA grafted peptides significantly inhibited DC-T cell conjugation
DC - T cell conjugation is needed to induce T cell proliferation and differentiation. To
evaluate the effect of the HA and HA with grafted peptides on DC - T cell conjugate
formation, OVA loaded-DCs labeled with CFSE were treated with HA, HA with grafted
LABL and HA with grafted LABL and OVA for 30 min and co-incubated with CMTMR-
loaded T cells prepared from OT-II mice. In the presence of HA, HA with grafted LABL
and HA with grafted LABL and OVA, conjugation of DCs and T cells was reduced
significantly compared to untreated groups (Figure 4A). The percentage of T cells – DC
interactions in media (~40%) as compared to treatments with HA (~9%), HA with grafted
LABL (~8%), and HA with grafted LABL and OVA (~6%), correlating to a decrease of
79%, 82 and 85%, respectively, when compared to T cell with media treated DCs (Figure
4B).
METHODS
Cell culture and isolation
Bone marrow derived dendritic cells were generated from C57BL/6 wildtype mice as
described.24 Briefly, 2 × 106 cells were isolated from bone marrow, plated on bacterial Petri
dishes and cultured in 10 mL DC media (RPMI 1640, 10% heat inactivated fetal bovine
serum, 100 µg/mL penicillin-streptomycin, 50 µM β-mercaptoethanol, 20 ng/mL murine
granulocyte macrophage colony stimulating factor (GM-CSF) (R&D), and 2 nM L-
glutamine. At 72 hours (Day 3), 10 mL of fresh DC media was added to each dish. On days
6 and 8, 10 mL of supernatant and cells were removed, cells recovered by centrifugation
(90× g) and added back to the dish with fresh DC medium. On day 9 non-adherent cells
were collected. On day 10, T cells were isolated from C57BL/6-TgN(OT-II.2a)-Rag1
spleens by passing spleens through a wire mesh. T cells were purified using a negative 178
selection, mouse T cell enrichment kit according to manufacturer’s directions (EasySep).
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Peptides were synthesized using 9-fluorenylmethyloxycarbonyl-protected amino acid
chemistry on polyethylene glycol-polystyrene resins, with an aminooxy carboxylic acid
residue added to the N-terminus. The peptides synthesized were aminooxy-LABL
(aminooxy-ITDGEATDSG, Ao-LABL), a cell-adhesion molecule antagonist, and aminooxy-
ovalbumin peptide (OVA) (aminooxy–ISQAVHAAHAEINEAGR, Ao-OVA), a OVA
antigen epitope. Peptides were deprotected, cleaved from resin, and isolated using
precipitation in ether. Peptides were purified by preparatory high performance liquid
chromatography (HPLC) followed by lyophilization. The identity of the synthesized peptide
was confirmed by electrospray ionization mass spectrometry and purity of peptides was
assessed using analytical HPLC.
Conjugation of LABL and OVA peptide to HA polymer
The aminooxy group of peptides was linked to hyaluronic acid. Peptides were mixed in a 1:2
molar ratio to the polymer reactive sites. Peptide-HAs were prepared by dissolving HA-
FITC polymer (20 mg) in acetate buffer solution (20 mM, 5 mL) of pH 5.5 ± 0.1. Then,
LABL peptide (27.8 mg) or OVA peptide (49.4 mg) was added and mixed gently. Reaction
solutions were then stirred at 500 RPM using magnetic stir bars for 24 hrs at room
temperature. HA with grafted LABL and OVA was prepared by adding LABL (13.8 mg)
and OVA (24.8 mg) peptides simultaneously to HA-FITC (20 mg) in solution. Each solution
of HA graft polymer was then transferred to dialysis bags (MWCO 3500 Da) and was
dialyzed for 24 hrs with changing of water at least once to remove free peptides. The
peptide-HAs were lyophilized.
Characterization of HA LABL and/or OVA graft polymer
The amount of LABL and OVA peptides conjugated on HA were quantified by determining
the amount of unreacted free peptides in reaction medium using gradient reversed phase
HPLC (SHIMADZU) using a C18 column. Additionally, the amount of peptide conjugated
to HA for each of the graft conjugates was determined by digested in conjugated in acidic
medium then running on HPLC as previously reported.11 The HPLC consisted of SCL-10A
SHIMADZU system controller, LC-10AT VP SHIMADZU liquid chromatograph, SIL-10A
XL SHIMADZU auto injector set at 30 µL injection volume, DGU-14A SHIMADZU
degasser, sample cooler, and SPD-10A SHIMADZU UV-Vis detector (220 nm). The HPLC-
UV system was controlled by a personal computer equipped with SHIMADZU class VP
Software. All separations were carried out using a VydacR 179 HPLC Protein and Peptide
C18 column. Gradient elution was carried out to determine the amount of LABL and OVA
peptide at constant flow of 1 mL/min. Gradient elution was carried out to determine the
amount of LABL peptide at constant flow of 1 mL/min, Mobile phase compositions were
(A) acetonitrile-water (5:95) with 0.1% TFA and (B) 100% acetonitrile with 0.1%
trifluoroacetic acid (TFA).
Characterization of HA and HA graft polymer conjugate stability in RPMI media
To assess the stability of HA and the manufactured graft polymer conjugates in cell culture,
samples were prepared in RPMI media and then stored at 37 °C. At defined time points, 100
µL of sample was taken and analyzed using the Shimadzu HPLC system with a refractive
index detector and Agilent PL-Aqua gel-OH SEC/GPC chromatography Columns. Isocratic
elution was carried out with 0.1 M Ammonium Acetate with 0.25 M NaCl at pH 5 buffer at
a constant flow of 0.6 mL/min for 45 min.
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Binding of HA, HA with grafted LABL, HA with grafted OVA, and, HA with grafted LABL
and OVA on DCs
The binding of HA, HA with grafted LABL, HA with grafted OVA, or HA with grafted
LABL and OVA was monitored using fluorescence microscopy. The HA of all samples
included a FITC label, unless otherwise mentioned. DCs (1 × 105 cells/mL) were added in
an 8 well-plate (200 µL/well) and loaded with OVA (50 µg/mL) and matured with TNF-α
(1,000 U/mL) for 24 hrs. DCs were washed with PBS and incubated with HA, HA with
grafted LABL, HA with grafted OVA, or HA with grafted LABL and OVA (2 mg/mL, 300
µL) at 37 °C for 15 min. Cells were washed three times with PBS and fixed with 4%
paraformaldehyde.
Fluorescence micrographs were acquired using the FITC filter set of a Nikon Eclipse 80i
microscope equipped for epifluorescence. Micrographs were captured using an Orca ER
camera (Hamamatsu, Inc., Bridgewater, NJ) and analyzed by Metamorph, version 6.2
(Universal Imaging Corp., West Chester, PA). All images were corrected for variations in
excitation light intensity. Mean fluorescent intensity of cells incubated with HA graft
polymers was determined by using ImageJ software.
The binding of HA graft polymers on DCs was also determined and analyzed by using a
fluorescence spectrophotometer. DCs were loaded with OVA (50 µg/mL) and matured with
TNF-α (1,000 U/mL) for 24 hr. Cells were washed three times with serum free RPMI1640
and incubated with HA, HA with grafted LABL, HA with grafted OVA, or HA with grafted
LABL and OVA in serum free medium (2 mg/mL) for 15 min. After incubation, cells were
washed three times with ice-cold PBS. HA graft polymers associated with the DCs were
detected and compared using a fluorescence plate reader (Spectramax M5; ex: 450 nm, em:
500 nm).
Calculation of T cell and DC conjugate formation
DCs (4 × 105 cells/ml) were stained by incubating with 5 ml of CFSE in PBS (10 µM) for 10
min at 37 °C in PBS. The reaction of dye was quenched by the addition of 25 ml of
complete culture medium and incubation at 4°C for 10 min. The remaining dye was washed
away three times with complete culture medium. T cells were incubated with 10 µl of
CMTMR orange fluorescent dye (5 µM) in 10 ml of PBS for 30 min at 37°C. The staining
was quenched by incubating with complete culture medium for 30 min at 37°C followed by
washing three times with complete culture medium. Dendritic cells (4 × 105 cells/ml) loaded
with OVA (50 µg/ml) and activated with TNF-α (1,000 U/ml) were incubated with FITC
labeled HA, HA with grafted LABL, and HA with grafted LABL and OVA (2 mg/ml) for 30
min at 37 °C. Untreated DCs were used as a positive control. Then, T cells (2 × 106 cells/ml)
were incubated with DCs for 2 hr at 37 °C, washed three times with PBS and fixed with 4%
paraformaldehyde. Cells were imaged using an Orca ER camera (Hamamatsu, Inc.,
Bridgewater, NJ) and analyzed by Metamorph, version 6.2 (Universal Imaging Corp., West
Chester, PA). Number of T-cells attached to dendritic cells (red) and dendritic cells (green)
were determined by analyzing red and green pixels, respectively by imaging analysis
software. The percentage of T cell-conjugates was calculated.
To complete the T cell proliferation assay, primary T cells isolated from C57BL/6-TgN(OT-
II.2a)-Rag1 mice were labeled with CFSE (5 µM) for 10 min at 37 °C, 5% CO2 to observe
cell division by CFSE dilution. The dye reaction was quenched by the addition of 5 volumes
of culture medium into T cells and incubated 10 min at 4°C. DCs (4 × 105 cells/mL) were
loaded with OVA (50 µg/mL) and matured with TNF-α (1,000 U/mL) for 24 hrs in 24-well
plate. DCs were treated with HA, HA with grafted LABL, HA with grafted OVA, or HA
with grafted LABL and OVA (2 mg/mL) for 30 min, at 37 °C, 5% CO2 and washed three
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times with PBS. T cells (2 × 106 cells/mL) in serum free RPMI1640, IL-2 and 1% penicillin-
streptomycin were incubated with DCs 7 days at 37 °C, 5% CO2. T cells collected after 24
hrs (1 day) and 168 hrs (7 days) were centrifuged at 16,089 g for 2 minutes and fixed with
4% paraformaldehyde. The CFSE dilution was measured by using FACScan flow cytometer.
The percent of T cell proliferation was analyzed by calculating the percent of cells with
diluted CFSE using FlowJo software.
Quantification of cytokines in cell culture supernatants by ELISA
DCs were loaded with OVA (50 µg/mL) and matured with TNF-α (1,000 U/mL) for 24 hrs
in 24-well plate. DCs were treated with HA, HA with grafted LABL, HA with grafted OVA,
or HA with grafted LABL and OVA (2 mg/mL) for 30 min, at 37 °C, 5% CO2 and washed
three times with PBS. T cells (2 × 106 cells/mL) in serum free RPMI1640, IL-2 and 1%
penicillin-streptomycin were incubated with DCs 7 days at 37 °C, 5% CO2. Supernatants of
cell cultures were collected for cytokine detection. Secreted IFN-γ, TNF-α, IL-4, IL-10 and
IL-17 were measured by an ELISA assay (Cytokine Core Lab, Baltimore, Maryland).
ELISA was performed in Nunc Maxisorb ELISA strips freshly coated with capture antibody
for 16 hours before the assay was performed. Detecting antibody and the streptavidin
peroxidase conjugate were added into standard, all samples, and controls. Premixed
substrate solution (Neogen) was then added. The plate was read on a Molecular Devices
ELISA plate reader. Curve fitting was selected among linear, quadratic, and 4-point based
on the best regression coefficient using the SoftPro software package.
Statistical analysis
Statistical evaluation of data was performed using an analysis of variance (one-way
ANOVA). Newman–Keuls was used as a post-hoc test to assess the significance of
differences. To compare the significance of the difference between the means of two groups,
a t-test was performed; in all cases, a value of p < 0.05 was accepted as significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Binding of HA graft polymers to dendritic cells loaded with OVA and matured with TNF-α.
(A) Micrographs of DCs incubated with HA graft polymers for 15 min. (B) Fluorescent
intensities of DCs as quantified from fluorescence micrographs. (C) Fluorescent intensities
of DCs were confirmed using fluorescence spectroscopy. Data are presented as mean ± S.D.
(n=3). *** indicates p<0.001 and ** indicates p<0.05 and * indicates p<0.01.
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Proliferation of T cells co-cultured with DCs for 1 day and 7 days. T cell proliferation was
determined by using flow cytometry. Data are presented as mean ± S.D. (n=3). ** indicates
p<0.01 and * indicates p<0.05.
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(A) The production of TNF-α in T cell/DC co-cultures where DCs were pretreated with HA,
HA with grafted LABL, or HA with grafted LABL and OVA. HA and HA graft polymers
decreased the secretion of TNF-α compared to untreated DCs (*** indicates p<0.001 and **
indicates p<0.01). (B) IL-17 in the same co-cultures of T cells and DCs pretreated with HA,
HA with grafted LABL, or HA with grafted LABL and OVA was undetectable. Data
presented as mean ± S.D. (n=3).
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(A) Cell co-localization pictures showing T cells (green) and dendritic cells (red) and
immunological synapse formation for (a) Media alone (b) HA alone (c) HA with grafted
LABL (d) HA with grafted LABL and OVA. (B) Percent of T cell-DC conjugate formation
analyzed by imaging analysis software. HA and HA with grafted peptides show a drastic
decrease in conjugate formation between T cells and DCs. (*** indicates p<0.001)
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21.69 - 41 32
- 24.9 47 37
11.74 12.07 45 35
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